(BWI); Biocon Ltd has earned the distinction of being the only Asian Biopharma Company to feature among the top biotechnology employers in the world as ranked by Science magazine. The ranking is a result of a global survey conducted by the American Association for the Advancement of Science (AAAS) through its affiliate Science magazine to determine which companies in the biotech and pharmaceutical industry have the best reputations as employers globally.
(BWI); Anand Diagnostic Lab, one of India‘s oldest and leading, stand-alone diagnostic services company, launched a new drive-through blood collection service that will help customers reduce the time and effort required to give samples for required tests.
Sanofi and BioNTech announced that they have entered into a multiyear exclusive collaboration and license agreement. This research collaboration between Sanofi and BioNTech will leverage the scientific expertise of the two organizations to discover and develop up to five cancer immunotherapies, each consisting of a mixture of synthetic messenger RNAs (mRNAs).
Valeant Pharmaceuticals informed that it was cutting ties with mail-order pharmacy Philidor RX, which will shut down operations as soon as possible.
[adsense:336x280:8701650588]
Glenmark Pharmaceuticals Inc USA (Glenmark), has been granted tentative approval by the United States Food & Drug Administration (FDA) for its lacosamide tablets, 50 mg, 100 mg, 150 mg and 200 mg, the generic version of Vimpat tablets, 50 mg, 100 mg, 150 mg and 200 mg of UCB Inc.
U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery.
Melanoma, the most aggressive type of skin cancer, is the leading cause of death from skin cancer. Patients with stage III melanoma are generally treated by surgery to remove the melanoma skin lesions and the nearby lymph nodes.
Indian Immunologicals Ltd (IIL), a leading biological company inaugurated its new bovine serum manufacturing facility in New Zealand.
Strengthening its over the counter (OTC) portfolio, Pharma major Dr. Reddy's Laboratories on Monday announced the launch of Nise D spray, which offers quick and targeted pain killing.
Sun Pharmaceutical Industries Ltd.successfully completed cash tender offered by by Thea Acquisition Corp. (“Thea”), an indirect wholly owned subsidiary of Sun Pharma, for all outstanding shares of common stock of InSite Vision Incorporated (OTCBB: INSV, InSite), which expired at 12:00 midnight, New York City time, (the end of the day) on Tuesday, October 27, 2015.
16% local currency operating profit growth adjusted for the NNIT divestment
Sales increased by 23% in Danish kroner and by 9% in local currencies to DKK 79.1 billion.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
